Mephedrone
| 4-MMC | |
|---|---|
| Salts [] | |
|---|---|
| Mephedrone hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 177.24 g/mol [1] |
| Appearance | Fine-white to off-white or slightly colored powder ... also found in tablet or capsule form [1] |
| Predicted LogP | 2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C11H15NO |
| IUPAC name | 2-(methylamino)-1-(4-methylphenyl)propan-1-one |
| SMILES | CC1=CC=C(C=C1)C(=O)C(C)NC |
| InChI | InChI=1S/C11H15NO/c1-8-4-6-10(7-5-8)11(13)9(2)12-3/h4-7,9,12H,1-3H3 |
| InChIKey | YELGFTGWJGBAQU-UHFFFAOYSA-N |
| CAS number | 1189805-46-6 |
| UNII | 8BA8T27317 |
| PubChem CID | 45266826 |
| Pharmacokinetics[] | |
|---|---|
| Routes of administration | Oral, insufflation, IV, rectal |
| Dosing[] |
|---|
| Insufflated [] | |
|---|---|
| Light | ≤ 75.3 mg(1550x - 30.5%) |
| Common | 75.3 - 90 mg(1145x - 22.5%) |
| Strong | 90 - 110 mg(1169x - 23.0%) |
| Heavy | 110 - 130 mg(726x - 14.3%) |
| Extreme | 130 mg +(498x - 9.8%) |
| Intravenous [] | |
|---|---|
| Light | ≤ 47.6 mg(81x - 27.6%) |
| Common | 47.6 - 60 mg(94x - 32.0%) |
| Strong | 60 - 80 mg(56x - 19.0%) |
| Heavy | 80 - 100 mg(34x - 11.6%) |
| Extreme | 100 mg +(29x - 9.9%) |
| Oral [] | |
|---|---|
| Light | ≤ 173.4 mg(146x - 37.2%) |
| Common | 173.4 - 200 mg(69x - 17.6%) |
| Strong | 200 - 300 mg(91x - 23.2%) |
| Heavy | 300 - 367.7 mg(43x - 11.0%) |
| Extreme | 367.7 mg +(43x - 11.0%) |
| Intrarectal [] | |
|---|---|
| Light | ≤ 76.1 mg(13x - 36.1%) |
| Common | 76.1 - 98 mg(5x - 13.9%) |
| Strong | 98 - 121.3 mg(9x - 25.0%) |
| Heavy | 121.3 - 183.4 mg(2x - 5.6%) |
| Extreme | 183.4 mg +(7x - 19.4%) |
| Vaporized [] | |
|---|---|
| Light | ≤ 8 mg(4x - 36.4%) |
| Common | 8 - 9 mg(2x - 18.2%) |
| Strong | 9 - 11.5 mg(2x - 18.2%) |
| Heavy | 11.5 - 13 mg(2x - 18.2%) |
| Extreme | 13 mg +(1x - 9.1%) |
Statistically derived dosages via DBI-IGS (archived by anodyne.wiki) We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly. |
Mephedrone (also known as 4-methylmethcathinone, Meow meow, M-cat, 4-methylephedrone, bk-4-methylmethamphetamine, β-keto-4-methylmethamphetamine, J2.756.280i, 1-Propanone, 2-(methylamino)-1-(4-methylphenyl)-, MMCAT compound or 4-MMC compound) is a substance of the cathinone class.
Chemistry
Salts []
Stereochemistry []
Mephedrone is a racemic mixture of the enantiomers (optical activity ( + / - )).
| Stereoisomerism |
|---|
| Stereoisomers from PubChem |
Druglikeness
Lipinski's rule of five
Mephedrone matches Lipinski's rule of five.Reagents
There are currently 13 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | no change or yellowish | |
| Mecke | no color change | |
| Mandelin | short reddish | |
| Liebermann | yellow / orange | |
| Froehde | no color change | |
| Robadope | no pink color change | |
| Simon's | slow blue | |
| Ehrlich | no color change | |
| Hofmann | no color change | |
| Scott | blue spots | |
| Morris | purple | |
| Zimmermann | purple ring / brown | |
| Gallic | no color change |
Pharmacology
Mechanism of action []
As with phenethylamines, in the absence of ring-substitution, cathinones behave predominantly as central nervous system (CNS) stimulants, although generally with a lower potency than the corresponding phenethylamine analogue. The lower potency is caused by the beta-keto group creating a more polar molecule with lower ability to cross the blood-brain barrier. In the presence of ring substitution, however, the properties are modified towards MDMA-like effects. [1]
Subjective effects []
| 0xea / Mephedrone [] | |
|---|---|
Routes:
| |
| a1ko / Mephedrone [] | |
|---|---|
Routes:
| |
| emily / Mephedrone [] | |
|---|---|
Routes:
| |
| Mere / Mephedrone [] | |
|---|---|
| michalina / Mephedrone [] | |
|---|---|
Effects:
| |
| Pilz / Mephedrone [] | |
|---|---|
Routes:
| |
Experience reports
Erowid
There are currently 30 experience reports involving mephedrone on Erowid: []- "Interesting, but not MDMA" by crunknasty
- "Rubbery Abandon" by Harmoniousaccord
- "Not for Human Consumption" by Arthur H.
- "Looking Back" by Doomknot
- "Serious Addiction Potential" by hyperspacepilot
- "Sparkle" by Jovialla
- "Wasting a Night on Unknown Chemicals" by Smushy
- "Something Very Dark About This" by birdkid
- "Good Alternative to MDMA" by Meph_Test
- "Well, Now. Ain't That Something" by Trichilia
- "Dangerously Addictive, but Awesome" by Fazer
- "Good but Frustrating" by non3
- "Far Too Much" by Bazza
- "Feels Like My First 'E'" by scidhyv
- "Testing a New Friend" by dmtdoodeelsd
- "A New Stimulus" by Palmer Eldridge
- "Putting Our Mephedrone to Rest..." by Leprechaun
- "A New Experience Then Disappointment" by veekocs9
- "Loss of Control and Detachment From Reality" by Ricket
- "Oral ROA vs Insufflation" by Doctor
- "Euphoria in a Clear Bag" by Alkaline Love
- "Three Years and Three Substances" by tomunist
- "Defies Logic" by Seven Psyruz
- "Pace Yourself Race Horse" by Mike
- "A Basic Overview of the IV ROA" by Big E
- "Just another Drone" by Riddler
- "A Successful Relationship with It" by Society
- "In the Zone" by Cyberdelic Traveler
- "Incredible Zingy Feelings but Awful Comedown" by Scribblenipple
- "Energy Motivation with OCD and ADHD" by PsychonautRN
Legal status []
- Australia: Mephedrone is a Schedule 9.
- Brazil: Mephedrone is a F2.[3]
- Germany: Mephedrone is a Anlage I under the "Betäubungsmittelgesetz (BtMG)".
- United Kingdom: Mephedrone is a Class B under the "Misuse of Drugs Act 1971".
- United States: Mephedrone is a Schedule I under the "Controlled Substances Act".
- United Nations: Mephedrone is a Schedule II psychotropic under the "Convention on Psychotropic Substances 1971".[4]
- Other: Mephedrone is a SE: Förteckning I.[5]
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 45266826, Mephedrone. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/45266826
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Mephedrone. UNII: 8BA8T27317. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/8BA8T27317
RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-07-24. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451
Substance Details 4-Methylmethcathinone. https://www.unodc.org/LSS/Substance/Details/26beacc1-da0e-4543-8f51-a3d54e6d6678
Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika. Läkemedelsverket. https://www.lakemedelsverket.se/globalassets/dokument/lagar-och-regler/lvfs/lvfs-2011-10-konsoliderad.pdf
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | ok | 2026-11-20 13:01:06 |
| drugspro | ok | 2026-11-20 13:01:01 |
| erowid | ok | 2026-11-20 13:01:04 |
| gsrs | ok | 2026-11-20 13:01:02 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0041923) | 2026-11-20 13:01:01 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 13:01:06 |
| pubchem | ok | 2026-11-20 13:01:00 |
| missing (no r/tripreports posts mention it) | 2026-11-20 13:01:01 | |
| sider | missing (not in SIDER) | 2026-11-20 13:01:01 |
| structure | ok | 2026-11-20 13:01:01 |
| wikipedia | ok | 2026-11-20 13:01:02 |